This was successfully posted to your pofile.
This box will close automatically in a few seconds. Close this window
We don't have an e-mail address on file for you. To use AAFP Connection, you must have an e-mail address in our records. Click Here
Risk to Fetuses, Depressed Patients Prompts Citalopram, Finasteride Recall
Drugs Are Mislabeled, Says Manufacturer
By News Staff
Moreover, patients who discontinue citalopram abruptly by inadvertently taking the mislabeled finasteride product may experience discontinuation symptoms and/or worsening of their depression.
Conversely -- because citalopram is contraindicated in patients who take monoamine oxidase inhibitors, which also are antidepressants, or pimozide, an antipsychotic drug -- patients already taking one of these drugs who then also take citalopram that has been mislabeled as finasteride may experience serious adverse effects.
Greenstone said bottles of citalopram and finasteride with the affected lot number should be returned to the pharmacy where they were purchased. Patients who may have ingested the wrong medication should contact their physicians as soon as possible.
Adverse events related to the use of these products should be reported to the FDA's MedWatch program.